He reported improved sleep quality, increased daytime energy and is clinically doing well 10 months after implant. The central apnea index was zero and there were no Cheyne stoke respirations pre and post-implant. CONCLUSION. The INSPIRE device is effective and safe following Orthotopic Heart ...
Inspire therapy is indicated for patients with moderate to severe OSA who do not have significant central sleep apnea and do not have a complete concentric collapse of the airway at the soft palate level. We sell our Inspire system to hospitals and ambulatory surgery centers ("ASCs") in the...
Central Sleep Apnea (CSA) Central Sleep Apnea occurs when your brain forgets to breathe during sleep. Complex or Mixed Sleep Apnea (CompSA) Complex Sleep Apnea occurs when both obstructive sleep apnea events and central sleep apnea events occur during sleep. ...
and business development roles in the U.S. and internationally. Before joining Inspire, he developed peripheral and central neuromodulation therapies for Medtronic. Mr. Rondoni is an inventor of over 100 U.S. patents; he holds a B.S. and M.Eng. from the Massachusetts Institute of Technology...
Citations may include links to full-text content from PubMed Central and publisher web sites.doi:10.1016/j.gie.2013.11.006CohenLawrence B.Mosby, Inc.Gastrointestinal EndoscopyCohen LB. Inspire or expire: the safety of endoscopic sedation in patients with sleep apnea. Gastrointest Endosc. 2014;79(...